Suppr超能文献

[新克隆的硝基还原酶基因NOR1的表达及表达产物的纯化]

[Expression of a new cloned nitroreductase gene NOR1 and purification of expressed product].

作者信息

Nie Xin-Min, Xiao Bing-Yi, Li Xiao-Ling, Zhang Bi-Cheng, Li Wei-Fang, Wang Rong, Cao Li, Li Gui-Yuan

机构信息

Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan, 410078, PR China.

出版信息

Ai Zheng. 2003 Feb;22(2):136-9.

Abstract

BACKGROUND & OBJECTIVE: NOR(1)is a good candidate of tumor suppressor/susceptibility gene associated with nasopharyngeal carcinoma. This study was designed to construct the prokaryotic expression vector and to investigate the expression of nitroreductase gene NOR(1)in Escherichia coli and to purify expressed product.

METHODS

Total RNA was subtracted from normal nasopharyngeal carcinoma tissue. The full length of NOR(1)gene was amplified by reverse transcription-polymerase chain reaction (RT-PCR) and digested with BamHIand XhoI restriction endonucleases. The plasmid pGEX-4T-2 was also digested with BamHI and XhoI,then the NOR(1)gene was inserted into vector pGEX-4T-2. The recombinant expression vector pGEX-4T-2/NOR(1)was identified by sequencing and digested with restriction enzymes. E.coli Jm105 transformed with the recombinant plasmid was induced by IPTG to express GST fusion protein. The result was confirmed by Western blot analysis and the purified targeted protein was obtained by affinity chromatography.

RESULTS

The 1.25kb NOR(1)gene was successfully isolated. After induction, a new anticipated protein of 74 kDa appeared on sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE). It existed not only in supernatant but also in precipitation of broken bacteria. The result was confirmed by Western blot analysis,and the purified targeted protein was obtained by affinity chromatography.

CONCLUSION

The successes in construction of expression vector of NOR(1), expression and purification of GST/NOR(1)fusion protein make it possible to prepare for the polyantibodies for NOR(1).

摘要

背景与目的

NOR(1)是与鼻咽癌相关的肿瘤抑制/易感基因的良好候选基因。本研究旨在构建原核表达载体,研究硝基还原酶基因NOR(1)在大肠杆菌中的表达并纯化表达产物。

方法

从正常鼻咽癌组织中提取总RNA。通过逆转录-聚合酶链反应(RT-PCR)扩增NOR(1)基因全长,并用BamHI和XhoI限制性内切酶消化。质粒pGEX-4T-2也用BamHI和XhoI消化,然后将NOR(1)基因插入载体pGEX-4T-2。通过测序鉴定重组表达载体pGEX-4T-2/NOR(1),并用限制性酶消化。用IPTG诱导用重组质粒转化的大肠杆菌Jm105表达GST融合蛋白。通过蛋白质免疫印迹分析证实结果,并通过亲和层析获得纯化的目标蛋白。

结果

成功分离出1.25kb的NOR(1)基因。诱导后,在十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)上出现了一条新的预期的74 kDa蛋白条带。它不仅存在于上清液中,也存在于破碎细菌的沉淀中。通过蛋白质免疫印迹分析证实了结果,并通过亲和层析获得了纯化的目标蛋白。

结论

NOR(1)表达载体的构建、GST/NOR(1)融合蛋白的表达和纯化成功,为制备NOR(1)多克隆抗体奠定了基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验